Sternberg, Cora N <br/><br/>
Larotaxel with Cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: a randomized, active-controlled, phase III trial (CILAB).  [electronic resource] 

 -  Oncology  2013 
 - 208-15 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1423-0232 
<br/><br/><label>Standard No.: </label>10.1159/000354085  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Carcinoma, Transitional Cell--drug therapy<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Prospective Studies<br/>Survival Analysis<br/>Taxoids--administration & dosage<br/>Treatment Outcome<br/>Urinary Bladder Neoplasms--drug therapy<br/>Urothelium--pathology<br/>Gemcitabine